Vol 5 | Issue 3 | September – December 2019 | page: 5-7 | Dr. Francisco de Assis Serra Baima Filho.<\/p>\n
[1] Department of Orthopedic Oncology, Aldenora Bello Oncology Institute of Maranhao, Brazil.<\/p>\n
Address of Correspondence<\/span><\/strong> Introduction:<\/strong> Leiomyosarcoma is a rare smooth muscle mesenchymal neoplasm. The primary bone form is the rarest subtype. It mainly affects middle aged and female people. The most common complaint is the presence of a mass accompanied by pain. Diagnostic imaging and biopsy are required. The gold standard treatment is resection with oncologic margin. 1. Gordon RW, Tirumani SH, Kurra V, Shinagare AB, Jagannathan JP, Hornick JL, et al. MRI, MDCT features, and clinical outcome of extremity leiomyosarcomas: Experience in 47 patients. Skeletal Radiol2014;43:615- 22.
\nDr. Francisco de Assis Serra Baima Filho,
\nDepartment of Orthopedic Oncology, Aldenora Bello Orthopedic Oncology Institute of Maranhao (IMOAB), Brazil.
\nE-mail: assisbaima@gmail.com<\/p>\n
\nAbstract<\/span><\/h2>\n
\n
\nCase Report:<\/strong> A 20-year-old female had a history of tumor mass and left hip pain beginning in September 2018.The patient showed the radiographic examination, osteolytic lesion of the left hip, and computed tomography scan of the abdomen with a solid expansive process measuring 15.8 cm left hip destruction and absence of organ damage. Biopsy and immunohistochemical result of leiomyosarcoma. Neoadjuvant chemotherapy was not effective. Thus, we opted for tumor resection with internal hemipelvectomy Type I.
\nConclusion:<\/strong> Primary bone leiomyosarcoma is a rare malignant neoplasm which only shows tumoral resection with oncological margins as a curative treatment, thus the need for early diagnosis to allow adequate resection and lower patient morbidity.
\nKeywords:<\/strong> Leiomyosarcoma, case reports, rare diseases, literature review.<\/p>\n
\nReferences<\/span><\/h2>\n
\n
\n2. Tahara K, Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Endo M, et al. MR imaging findings of a leiomyosarcoma of the thoracic spine: A case report. Clin Neuroradiol 2016;26:229-33.
\n3. Mori T, Nakayama R, Endo M, Hiraga H, Tomita M, Fukase N, et al. Fortyeight cases of leiomyosarcoma of bone in Japan: A multicenter study from
\nthe Japanese musculoskeletal oncology group. J Surg Oncol 2016;114:495-500.
\n4. Rekhi B, Kaur A, Puri A, Desai S, Jambhekar NA. Primary leiomyosarcoma of bone–a clinicopathologic study of 8 uncommon cases
\nwith immunohistochemical analysis and clinical outcomes. Ann Diagn Pathol2011;15:147-56.
\n5. Potsi M, Stavrinou P, Patsinakidis N, Hatzibougias D, Foroglou N, Karayanopoulou G, et al. Primary osseous leiomyosarcoma of the spine: A
\nrare entity–case report and review of the literature. J Neurol Surg A Cent Eur Neurosurg2012;73:238-42.
\n6. Yang Y, Ma L, Li L, Liu H. Primary leiomyosarcoma of the spine: A case report and literature review. Medicine (Baltimore) 2017;96:e6227.
\n7. Zum\u00e1rraga JP, Arouca MM, Baptista AM, Caiero MT, Rubio DE, Camargo OP. Primary leiomyosarcoma of bone: Clinicopathologic and
\nprognostic factors analysis in a single institution. Acta Ortop\u00e9dica Bras 2019;27:152-5.
\n8. Recine F, Bongiovanni A, Casadei R, Pieri F, Riva N, De Vita A, et al. Primary leiomyosarcoma of the bone: A case report and a review of the literature. Medicine (Baltimore) 2017;96:e8545.<\/p>\n
\n